Positive list system re-emerging as contentious issue

Published: 2008-06-10 06:58:00

Updated: 2008-06-10 06:58:00

The government is firm in pushing for drug pricing reform, which it says cannot be the subject of transparency as it is part of the country's healthcare policies that ensure the financial stability of the national health insurance scheme by cutting down the prices of insurance-covered medicines.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK